UTMB researchers protect against lethal Ebola Sudan infection four days after infection

Researchers at The University of Texas Medical Branch at Galveston, in collaboration with Arbutus Biopharma Corporation, have protected nonhuman primates against Ebola Sudan four days following exposure to the virus. The study results, which were recently published in Nature Microbiology, demonstrated that the treatment was effective at a point when animals have detectable levels of ["]